{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:25:21Z","timestamp":1781652321831,"version":"3.54.5"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216399","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T13:26:21Z","timestamp":1559136381000},"page":"e0216399","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-8945","authenticated-orcid":true,"given":"Shinji","family":"Asada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Fukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihito","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10157-011-0502-5","article-title":"Diseases of the parathyroid gland in chronic kidney disease","volume":"15","author":"H Komaba","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"M Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41100-018-0183-6","article-title":"Annual Dialysis Data Report 2016, JSDT Renal Data Registry","volume":"4","author":"I Masakane","year":"2018","journal-title":"Ren Replace Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"AS Go","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","year":"2013","journal-title":"Ther Apher Dial"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1053\/j.ajkd.2013.08.011","article-title":"Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: Evidence from marginal structural models used to adjust for time-dependent confounding","volume":"63","author":"M Fukagawa","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10157-016-1293-5","article-title":"Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis","volume":"21","author":"K Nishikawa","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"EF Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/sdi.12413","article-title":"Cinacalcet and Clinical Outcomes in Dialysis","volume":"28","author":"H Komaba","year":"2015","journal-title":"Semin Dial"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"P Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"EVOLVE Trial Investigators: Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"GM Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.2010.167","article-title":"Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients","volume":"78","author":"GA Block","year":"2010","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19612","DOI":"10.1038\/srep19612","article-title":"PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism","volume":"6","author":"T Akizawa","year":"2016","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1744-9987.2010.00906.x","article-title":"Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design","volume":"15","author":"S Fukuhara","year":"2011","journal-title":"Ther Apher Dial"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/aje\/kwi216","article-title":"Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count","volume":"162","author":"SR Cole","year":"2005","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"WA Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"K Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","year":"2008","journal-title":"Ther Apher Dial"},{"key":"ref19","unstructured":"Hernan MA, Robins JM. Causal Inference [Internet]. Chapman &amp; Hall\/CRC, 2018 [cited 2 Oct 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hsph.harvard.edu\/miguel-hernan\/causal-inference-book\/\" xlink:type=\"simple\">http:\/\/www.hsph.harvard.edu\/miguel-hernan\/causal-inference-book\/<\/ext-link>"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"JM Robins","year":"2000","journal-title":"Epidemiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"MA Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1536867X0400400403","article-title":"Controlling for time-dependent confounding using marginal structural models","volume":"4","author":"Z Fewell","year":"2004","journal-title":"Stata Journal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"LD Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-11-80","article-title":"Alternative statistical methods for estimating efficacy of interferon beta-1b for multiple sclerosis clinical trials","volume":"11","author":"MN Mieno","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s Regression Model for Counting Processes: A Large Sample Study","volume":"10","author":"PK Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"ref26","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations in R","volume":"45","author":"S van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"J Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"P Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000347145","article-title":"Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism","volume":"122","author":"SR Choi","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial","volume":"132","author":"SM Moe","year":"2015","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2012.116","article-title":"The role of FGF23 in CKD- with or without klotho","volume":"8","author":"H Komaba","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e48070","DOI":"10.1371\/journal.pone.0048070","article-title":"Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis","volume":"7","author":"Q Zhang","year":"2012","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:23:24Z","timestamp":1588962204000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216399"}},"subtitle":[],"editor":[{"given":"Hideharu","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216399","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]}}}